Search Within

Kevin Joseph Curran

  1. "Immunology Program Faculty"
Formats
  1. Meeting Abstract (32)
  2. Journal Article (18)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (52)
  2. GSK Faculty (52)
  3. Immunology Program Faculty (52)
  4. Pediatrics, Department of (52)
  5. Sloan Kettering Institute Faculty (52)
  6. Stem Cell Transplantation and Cellular Therapy Service (52)

More Groups

People
  1. Richard O'Reilly (51)
  2. Nancy Kernan (48)
  3. Andromachi Scaradavou (40)
  4. Farid Boulad (40)
  5. Susan Prockop (40)
  6. Maria Cancio (27)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (2)
  5. 2021 (1)
  6. 2020 (10)

More Years

Publications
  1. Blood (15)
  2. Biology of Blood and Marrow Transplantation (11)
  3. Bone Marrow Transplantation (9)
  4. Blood Advances (3)
  5. Cytotherapy (3)
  6. Pediatric Blood and Cancer (3)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Elsevier Inc. (13)
  3. Nature Publishing Group (9)
  4. Elsevier Science Ltd. (3)
  5. Wiley Periodicals, Inc (3)
  6. American Society for Clinical Investigation (2)

More Publishers

Results (52)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Identification of infants with non-SCID immune deficiency by newborn screening for SCID - The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Prockop, S.; Spitzer, B.; Walsh, M.; Ruggiero, J.; Kennedy, J.; Boulad, F.; Cancio, M.; Curran, K.; Kernan, N.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
    Review

    Lee, D. W.; Santomasso, B. D.; Locke, F. L.; Ghobadi, A.; Turtle, C. J.; Brudno, J. N.; Maus, M. V.; Park, J. H.; Mead, E.; Pavletic, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save